Stage IIIA Colon Cancer AJCC v7
5 clinical trials · Condition
◉ Watch Stage IIIA Colon Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors (NCT03407716) | Mayo Clinic | 2019-03-01 |
| Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119) | City of Hope Medical Center | 2018-04-11 |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882) | SWOG Cancer Research Network | 2017-11-27 |
| Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561) | National Cancer Institute (NCI) | 2016-02-01 |
| Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer (NCT00096278) | National Cancer Institute (NCI) | 2004-09-15 |
Track Stage IIIA Colon Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.